Ozempic, Wegovy among drugs selected for Medicare's price negotiations
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.
CMS didn't wait for President-elect Donald Trump to take office before issuing its second list of drugs to be negotiated ...
The Centers for Medicare & Medicaid Services Jan. 17 announced a record 24.2 million consumers selected health coverage ...
Teva Pharmaceuticals is suing the Centers for Medicare & Medicaid Services (CMS) for its implementation of the drug price ...
The work of the Innovation Center has benefited from continuity across administrations; the path to further expanding ...
When it comes to ensuring patient safety, healthcare facilities operate under a complex regulatory framework, including ...
Alignment Healthcare is the latest Medicare Advantage (MA) insurer to accuse the Centers for Medicare & Medicaid Services ...
CMS has released its official 2025 mission and priorities document outlining its roadmap for state survey agencies Monday.
The Centers for Medicare and Medicaid Services took action in response to brokers changing policyholders' plans without their ...
A rule finalized Monday makes it easier for regulators to suspend agents and brokers from selling Affordable Care Act plans ...
At least 61,000 Ohioans could lose Medicaid benefits if President-elect Donald Trump's team approves Ohio's request to add a work requirement for the public health insurance, according to state ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback